Saturday February 29, 2020 14:03

Heathcare Press Release : 22 Jan 2020

Cognate BioServices closes Series B and completes acquisition of Cobra Heathcare—22 Jan 20

Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of Cobra Biologics, a leading CDMO specialized in